Functional response of the rat kidney to inhibition of nitric oxide synthesis: Role of cytochrome P450-derived arachidonate metabolites

British Journal of Pharmacology

Volumn 125, Issue 5, 1998, Pages 1065-1073

  Oyekan, Adebayo O ^a   McGiff, J C ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

20 HETEe; Cyclo oxygenase; CYP450; L NAME; Nitric oxide; Renal function

Indexed keywords

12,12 DIBROMODODECENOIC ACID; 20 HYDROXYEICOSATETRANOIC ACID; 5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; CLOTRIMAZOLE; CYTOCHROME P450; ENDOTHELIN A RECEPTOR; IFETROBAN; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DIURESIS; GLOMERULUS FILTRATION RATE; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; METABOLITE; NATRIURESIS; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT;

ANIMALS; ARACHIDONIC ACIDS; CYTOCHROME P-450 ENZYME SYSTEM; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HYDROXYEICOSATETRAENOIC ACIDS; KIDNEY; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; RECEPTORS, PROSTAGLANDIN; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; VIRAL PROTEINS;

EID: 0031731451     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702171     Document Type: Article

References (39)

1. ALONSO-GALICIA, M., DRUMMOND, H.A., REDDY, K.K., FALCK, J.R. & ROMAN, R.J. (1997). Inhibition of 20-HETE contributes to the vascular responses to nitric oxide. Hypertension, 29, 320-325.
2. 2 as an endothelium-derived contracting factor modulates endothelin-1-induced contraction. J. Hypertens., 12, 383-390.
3. ASKARI, B., BELL-QUILLEY, C.P., FULTON, D., QUILLEY, J. & MCGIFF, J.C. (1997). Analysis of eicosanoid mediation of the renal functional effects of hyperchloremia. J. Pharmacol. Exp. Ther., 282, 101-107.
4. BANTING, J.D., FRIBERG, P. & ADAMS, M.A. (1996). Acute hypertension after NO synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J. Hypertension, 14, 975-981.
5. BAYLIS, C., HARTON, P. & ENGELS, K. (1990). Endothelium-derived relaxing factor controls renal haemodynamics in the normal rat kidney. J. Am. Soc. Nephrol., 1, 875-881.
6. BOLGER, P.M., EISNER, G.M., RAMWELL, P.W., SLOTKOFF, L.M. (1978). Renal actions of prostacyclin. Nature, 271, 467-469.
7. BOULANGER, C.M. & LUSCHER, T.F. (1991). Hirudin and nitrates inhibit the thrombin-induced release of endothelin from the intact porcine aorta. Circ. Res., 68, 1768-1772.
8. DENG, A. & BAYLIS, C. (1993). Locally produced EDRF controls preglomerular resistance and the ultrafiltration coefficient. Am. J. Physiol., 264, F212-F215.
9. ESCALANTE, B., ERLIJ, D., FALCK, J.R. & MCGIFF, J.C. (1991). Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science, 251, 799-802.
10. ESCALANTE, B., SESSA, W.C., FALCK, J.R., YADAGIRI, P. & SCHWARTZMAN, M.L. (1989). Vasoactivity of 20-HETE is dependent on metabolism by cyclooxygenase. J. Pharmacol. Exp. Ther., 248, 299-232.
11. GOLIKORSKY, M.S., TSUKAHARA, H., MAGAZINE, H., ANDERSEN, T.T., MALIK, A.B. & BAHOU, W.F. (1994). Termination of endothelin signaling: Role of nitric oxide. J. Cell. Physiol., 158, 485-494.
12. GRUETTER, C.A., RYAN, E.T., LEMKE, S.M., BAILLY, D.A., FOX, M.K. & SCHOEPP, D.D. (1988). Endothelium-dependent modulation of angiotensin II-induced contraction in blood vessels. Eur. J. Pharmacol., 146, 85-95.
13. HARRIS, P.J., ZUO, J., MENDELSOHN, F.A.O. & SKINNER, S.L. (1991). Haemodynamic and renal tubular effects of low doses of endothelin in anaesthetized rats. J. Physiol., 433, 25-39.
14. HU, L. & MANNING, Jr, R.D. (1995). Role of nitric oxide in regulation of long-term pressure natriuresis relationship in Dahl rats. Am. J. Physiol., 268, H2375-H2383.
15. JACOBSON, H.R., CORONA, S., CAPDEVILLA, J., CHACOS, N., MANNA, S., WOMACK, A. & FALCK, J.R. (1984). Effects of epoxyeicosatrienoic acids on ion transport in the rabbit collecting tubule. In: P Braquet (ed). Prostaglandins and Membrane Ion Transport. New York: Raven Press. 311-318.
16. JOHNSON, R.A. & FREEMAN, R.H. (1992). Pressure natriuresis in rats during blockade of the L-arginine/nitric oxide pathway. Hypertension, 19, 333-338.
17. KHATSENKO, O.G., GROSS, S.S., RIFKIND, A.B. & VANE, J.R. (1993). Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc. Natl. Acad. Sci. U.S.A., 90, 11147-11151.
18. KING, A.J., BRENNER, B.M. & ANDERSON, S. (1989). Endothelin: a potent renal and systemic vasoconstrictor peptide. Am. J. Phyiol., 256, F1051-F1058.
19. KOUREMBANAS, S., MCQUILLAN, L.P., LEUNG, G.K. & FALLER, D.V. (1993). Nitric oxide regulates the expression of vasoconstrictor and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest., 92, 99-104.
20. MAKITA, K., TAKAHASHI, K., KARARA, A., JACOBSON, H.R., FALCK, J.R. & CAPDEVILLA, J.H. (1994). Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J. Clin. Invest., 94, 2414-2420.
21. MCGIFF, J.C. (1991). Cytochrome P-450 metabolism of arachidonic acid. Ann. Rev. Pharmacol. Toxicol., 31, 339-369.
22. MOREAU, P., TAKASE, H., KUNG, C.F., SHAW, S. & LUSCHER, T.F. (1997). Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension. Hypertension, 29, 763-769.
23. OYEKAN, A.O. (1994). The suppression by lipopolysaccharide of cytochrome P450-dependent renal vasodilation in the rat is mediated by nitric oxide. Eur. J. Pharmacol., 277, 123-132.
24. OYEKAN, A.O., BALAZY, M. & MCGIFF, J.C. (1997). Renal oxygenases: Differential contribution to vasoconstriction induced by endothelin-1 and angiotensin II. Am. J. Physiol., 273, R293-R300.
25. OYEKAN, A.O. & MCGIFF, J.C. (1998). Cytochrome P450-derived eicosanoids participate in the renal functional effects of endothelin-1 in the anaesthetized rat. Am. J. Physiol., 274, R52-R61.
26. A receptor activation. Am. J. Physiol., 264, R52-R61.
27. RIBEIRO, C.M., DUBAY, G.R., FALCK, J.R. & MANDEL, L.J. (1994). Parathyroid hormone inhibits Na(+)-K(+)-ATPase through a cytochrome P-450 pathway. Am. J. Physiol., 266, F497-F505.
28. RICHARD, V., HOGIE, M., CLOZEL, M., LOFFLER, B.M. & THUILLEZ, C. (1995). In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation, 91, 771-775.
29. ROMERO, M.F., MADHUN, Z.T., HOPPER, V. & DOUGLAS, J.G. (1990). An epoxygenase metabolite of arachidonic acid 5,6-epoxyeicosatrienoic acid mediates angiotensin-induced natriuresis in proximal tubular epithelium. Adv. Prostaglandin Thromboxane Leukot. Res., 31, 205-208.
30. SCHWARTZMAN, M.L., FALCK, J.R., YADAGIRI, P. & ESCALANTE, B. (1989). Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolites. J. Biol. Chem., 264, 11658-11662.
31. A antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide. J. Med. Chem., 37, 329-331.
32. A receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats. Circulation, 95, 240-244.
33. TAKAHASHI, K., CAPDEVILLA, J., KARARA, A., FALCK, J.R., JACOBSON, H.R. & BADR, K.P. (1990). Cytochrome P450-arachidonate metabolism in rat kidney: Characterization of hemodynamic responses. Am. J. Physiol., 258, F781-F789.
34. THOMPSON, A., VALERI, C.R. & LIEBERTHAL, W. (1995). Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats. Am. J. Physiol., 269, H743-H748.
35. THORUP, C. & PERSSON, A.E. (1994). Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism. Am. J. Physiol., 267, F606-F611.
36. TOPOUZIS, S., SCHOTT, C. & STOCLET, J.C. (1991). Participation of endothelium-derived relaxing factor and role of cGMP in inhibitory effects of endothelium on contractile responses elicited by α-adrenoceptor agonists in rat aorta. J. Cardiovasc. Pharmacol., 18, 670-678.
37. VALLANCE, P., COLLIER, J. & MONCADA, S. (1989). Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet, ii, 997-1000.
38. WINK, D.A., OSAWA, Y., DARBYSHIRE, J.F., JONES, C.R., ESHENAUS, S.C. & NIMS, R.W. (1993). Inhibition of cytochrome P450 by nitric oxide and a nitric oxide releasing agent. Arch Biochem. Biophys., 300, 115-123.
39. ZIYYAT, A., ZHANG, B-L. & BENZONI, D. (1996). Interactions between nitric oxide and prostanoids in isolated perfused kidneys of the rat. Br. J. Pharmacol., 119, 388-392.